OH ANDREW M. 4
4 · Rubius Therapeutics, Inc. · Filed Feb 4, 2019
Insider Transaction Report
Form 4
OH ANDREW M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-01-31+115,000→ 115,000 totalExercise: $13.69Exp: 2029-01-30→ Common Stock (115,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on January 31, 2020, then in 12 equal quarterly installments thereafter.